Get updates to this list
You’re signing up to all partnering opportunity alerts for:
Please check your inbox
Thank you for verifying your email. We have sent you a confirmation email containing a 6 digit verification code to complete your subscription
You've successfully created a subscription
The search results below each have a summary which you may find useful
in determining if the opportunity is what you’re looking for.
A research institute from northern Germany, active in metrology, has developed a traceable, spatial calibration technology which helps to determine calibration of therapeutic ultrasound devices factors more easily.... more
Certain diseases result in fibrosis of affected tissue. This 'scarring' causes reduced function compared to healthy tissue, which contributes to disease pathology. Wnt signalling is known to be important for tissue remodelling, such as that... more
This Irish SME has developed an animal warming and drying apparatus, optionally incorporating a radiant energy therapy means on upper & lower diffuser elements each deployable from a folded storage position. A combined air blower and heating... more
A French TTO acting on behalf major life science research labs in Paris Region, has designed and synthetized a new patented micro-particle which strongly improves the efficacy of a type of vaccines: ribonucleic acid (RNA) vaccines.
The proof... more
continuous release of the proteases encapsulated within at therapeutic doses during a sufficient period of time for the treatment of diseases which require a sustained protease administration during treatment... more
modulate the activation of the immune system have, therefore, a great potential in the identification of a therapeutic approach for a multiplicity of neurodegenerative and autoinflammatory pathologies. The inhibition... more
showed promising therapeutic results in a mouse model of ovalbumin induced allergy (egg allergy), providing a long-term effectiveness over a 10-month period study.
This treatment also provides a good preventive... more
immediate therapeutic action. Lymphoid neoplasms are conventionally treated with chemotherapy and radiotherapy of low specificity. The most common choice of treatment for mature B cell neoplasia is the multidrug... more
The residues responsible for chemokine-mediated receptor oligomerization are a therapeutic target that can be exogenously modulated in order to treat cancer metastasis, inflammatory and autoimmune diseases or HIV-1... more
Cervical cancer is the third most common cancer in women world-wide, with approx. 530,000 new cases and 275,000 deaths per year. In contrast to other cancers it mainly affects young women with a maximum of incidence below 30 years of age.
as therapeutic agents can be included. Depending on the variant it can be used in different clinical therapeutic areas.
This can lead to a broader possible commercial market, not... more
An Andalusian University in the south of Spain has developed a combination kit of GAL (1-15) or a pharmaceutically acceptable salt therof useful for augmenting and/or providing faster onset of the therapeutic effect... more
The Japanese company has developed two platform technologies: an in silico drug screening technology for small molecules (#1) and a new modality for therapeutic peptide (#2).
Technology #1 is being powered up... more
evaluation of the predicted therapeutic effect. At the same time, the effect of the medicinal agent on the dynamics of the thiol-disulfide ratio (TDR) in the blood as an integral indicator of the redox balance... more
therapeutic interventions with the latest digital solutions in a secure, user friendly web-based environment. It uses a blended approach where therapeutic interventions are supported... more
treatment in most of them leads to the continuous search for new therapeutic targets.
LRRK2 is a protein that has been classified as a member of the ROCO superfamily (Ras-like GTPase). Its physiological role is... more
and it has received very positive feedback from the patients, support groups and medical organizations. It makes a patient's life easier, improves a patient's motivation for treatment and intensifies the therapeutic... more
broad menu covering all the currently actionable molecular signatures. A constant update of new drugs/diagnostics development is a major focus of the approach proposed. It allows to immediately exploit the most advanced therapeutic... more
compounds), to be used for therapeutic and non-therapeutic purposes.
The center is looking to establish license, research cooperation or technical cooperation agreements with industrial... more
with cytotoxic compounds linked to anti-THSD7A antibodies to optimize site directed drug application and minimize therapeutic side effects.
Due to the strong relation to several tumor entities, THSD7A can be... more